We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 500kg
Packaging Information: 1) 25kg/drum Packed in a cardboard-drum with two plastic-bags inside; 2) 1kg/bag Packed in an aluminum foil bag; 3) As your request.
Delivery Lead Time: 3-5 days
Sample Provided: no
Feverfew Extract
Ⅰ Product Description
Clinical tests have shown the use of Feverfew Extract may reduce of frequency and severity of headaches. It may be more effective than other nonsteroidal antiinflammatories (NSAIDS), like aspirin. It is the combination of ingredients in the feverfew plant that brings such effective relief. It works to inhibit the release of two inflammatory substances, serotonin and prostaglandins, both believed to contribute to the onset of migraines. Feverfew Extract Used for the prevention of migraines & headaches, arthritis, fevers, muscle tension and pain, Feverfew is also used to lower blood pressure, lessen stomach irritation, stimulate the appetite and to improve digestion and kidney function.
Ⅱ Specification
PRODUCT NAME
feverfew extract
Botanical Source
Tanacetum Parthenium
Part USed
Leaf
Sepcification
0.2%-1.5%Parthenolide
Test Method
UV
Appearance
Brown Yellow Fine Powder
Ⅲ Function
1. Modulation of the NF-κB-mediated inflammatory responses in experimental atherosclerosis.
2. Activity against a parasite Leishmania amazonensis.
Six years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
